(Q46570350)

23 December 2017

title

Influence of age and gender on risperidone plasma concentrations (English)

1 reference

23 December 2017

1 reference

Wolfgang Aichhorn

1

1 reference

23 December 2017

Ulrike Weiss

2

1 reference

23 December 2017

Josef Marksteiner

3

1 reference

23 December 2017

Georg Kemmler

4

1 reference

23 December 2017

Thomas Walch

5

1 reference

23 December 2017

Gerald Zernig

6

1 reference

23 December 2017

Renate Stelzig-Schoeler

7

1 reference

23 December 2017

Christoph Stuppaeck

8

1 reference

23 December 2017

Christian Geretsegger

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 December 2017

Journal of Psychopharmacology

published in

1 reference

23 December 2017

volume

19

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

395-401

1 reference

23 December 2017

Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Clinical pharmacokinetic considerations in the elderly. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Gender differences in human pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Gender effects in pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

Effect of age and gender on tirilazad pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105053306

21 January 2018

Identifiers

DOI

10.1177/0269881105053306

1 reference

23 December 2017

PubMed ID

15982995

1 reference

23 December 2017